Hypogonadotropic Hypogonadism: Clinical Trials

3 trials for Hypogonadotropic Hypogonadism, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 33Completed 3

Follow Hypogonadotropic Hypogonadism: new trials by email Literature Review of Hypogonadotropic Hypogonadism trials Research Report on Hypogonadotropic Hypogonadism

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Corifollitropin Alfa (MK-8962) in Combination With Human Chorionic Gonadotropin (hCG) in Adolescent Males With Hypogonadotropic Hypogonadism (HH) (MK-8962-043)
Corifollitropin alfa, hCG - Hypogonadotropic Hypogonadism
Phase 3CompletedOrganon and Co172017-02-022024-05-23
Bioequivalence Study of Test and Reference Testosterone Topical Gel, 1.62% Metered Pump in Testosterone Deficient Adult Male Subjects Under Fasting Conditions
Testosterone Topical Gel, 1.62% Metered Pump, AndroGel (testosterone gel) 1.62% Metered-Dose Pump - Primary Hypogonadism, Hypogonadotropic Hypogonadism
Phase 3CompletedAmneal Pharmaceuticals, LLC322014-03-012014-06-26
A Study of the Efficacy and Safety of Corifollitropin Alfa (MK-8962) in Combination With Human Chorionic Gonadotropin (hCG) in Adult Men With Hypogonadotropic Hypogonadism (HH) (P07937)
Corifollitropin alfa, hCG - Hypogonadism, Hypogonadotropic Hypogonadism
Phase 3CompletedOrganon and Co182013-02-112024-05-24

Narrower conditions

Hypogonadism (3)

Broader conditions

Endocrine System Diseases (3)  ·  Gonadal Disorders (3)

Interventions

follicle stimulating hormone, human, with HCG C-terminal peptide (2)  ·  Testosterone (1)

Sponsors

Organon and Co (2)  ·  Amneal Pharmaceuticals, LLC (1)

Countries

Brazil (1)  ·  Denmark (1)  ·  Italy (1)  ·  Mexico (1)  ·  Russia (1)  ·  South Africa (1)  ·  United States (1)

Top investigators

Lawrence Galitz, MD (1)

Results publications

PMID 28270212

NIH funding

2015 (1)